Browsing Over 156 Presentations
Sort By
PSMA-targeted therapy: new horizons in mCRCP
DLL3-targeted agents in small-cell lung cancer
Panel discussion and Live Q&A
Treating unresectable Stage III NSCLC with immuno-oncology: A clinical case study
Live panel discussion and audience Q&A
Meeting close
Welcome and introduction
The role of immuno-oncology combinations in ES-SCLC: A clinical case study
At the cutting edge of cancer immunotherapy – in collaboration with SITC
Special session
Regulatory T cells: Biology and targeting
Lecture Time
13:05 - 13:20
Speakers
- Hiroyoshi Nishikawa (Tokyo, Japan)
Channel
Channel 3
Date
12.12.2020
Time
12:35 - 13:55
Authors
- Hiroyoshi Nishikawa (Tokyo, Japan)
At the cutting edge of cancer immunotherapy – in collaboration with SITC
Special session
Oncolytic viruses
Lecture Time
13:20 - 13:35
Speakers
- Kevin Harrington (London, United Kingdom)
Channel
Channel 3
Date
12.12.2020
Time
12:35 - 13:55
Authors
- Kevin Harrington (London, United Kingdom)
At the cutting edge of cancer immunotherapy – in collaboration with SITC
Special session
Q&A and live discussion
Lecture Time
13:35 - 13:51
Speakers
- All Speakers (, Switzerland)
Channel
Channel 3
Date
12.12.2020
Time
12:35 - 13:55
Authors
- All Speakers (, Switzerland)
At the cutting edge of cancer immunotherapy – in collaboration with SITC
Special session
Anti-angiogenic compounds improve immunotherapy outcomes
Lecture Time
12:35 - 12:50
Speakers
- Arjan Griffioen (Amsterdam, Netherlands)
Channel
Channel 3
Date
12.12.2020
Time
12:35 - 13:55
Authors
- Arjan Griffioen (Amsterdam, Netherlands)